Cargando…
DNA Nanotechnology for Cancer Therapy
DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostruct...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805665/ https://www.ncbi.nlm.nih.gov/pubmed/27022418 http://dx.doi.org/10.7150/thno.14203 |
_version_ | 1782423181864206336 |
---|---|
author | Kumar, Vinit Palazzolo, Stefano Bayda, Samer Corona, Giuseppe Toffoli, Giuseppe Rizzolio, Flavio |
author_facet | Kumar, Vinit Palazzolo, Stefano Bayda, Samer Corona, Giuseppe Toffoli, Giuseppe Rizzolio, Flavio |
author_sort | Kumar, Vinit |
collection | PubMed |
description | DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostructures called DNA origami. Here, we analyze the DNA origami and DNA-based nanostructures as a drug delivery system. Besides their physical-chemical nature, we dissect the critical factors such as stability, loading capability, release and immunocompatibility, which mainly limit in vivo applications. Special attention was dedicated to highlighting the boundaries to be overcome to bring DNA nanostructures closer to the bedside of patients. |
format | Online Article Text |
id | pubmed-4805665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-48056652016-03-28 DNA Nanotechnology for Cancer Therapy Kumar, Vinit Palazzolo, Stefano Bayda, Samer Corona, Giuseppe Toffoli, Giuseppe Rizzolio, Flavio Theranostics Review DNA nanotechnology is an emerging and exciting field, and represents a forefront frontier for the biomedical field. The specificity of the interactions between complementary base pairs makes DNA an incredible building material for programmable and very versatile two- and three-dimensional nanostructures called DNA origami. Here, we analyze the DNA origami and DNA-based nanostructures as a drug delivery system. Besides their physical-chemical nature, we dissect the critical factors such as stability, loading capability, release and immunocompatibility, which mainly limit in vivo applications. Special attention was dedicated to highlighting the boundaries to be overcome to bring DNA nanostructures closer to the bedside of patients. Ivyspring International Publisher 2016-03-20 /pmc/articles/PMC4805665/ /pubmed/27022418 http://dx.doi.org/10.7150/thno.14203 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Review Kumar, Vinit Palazzolo, Stefano Bayda, Samer Corona, Giuseppe Toffoli, Giuseppe Rizzolio, Flavio DNA Nanotechnology for Cancer Therapy |
title | DNA Nanotechnology for Cancer Therapy |
title_full | DNA Nanotechnology for Cancer Therapy |
title_fullStr | DNA Nanotechnology for Cancer Therapy |
title_full_unstemmed | DNA Nanotechnology for Cancer Therapy |
title_short | DNA Nanotechnology for Cancer Therapy |
title_sort | dna nanotechnology for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805665/ https://www.ncbi.nlm.nih.gov/pubmed/27022418 http://dx.doi.org/10.7150/thno.14203 |
work_keys_str_mv | AT kumarvinit dnananotechnologyforcancertherapy AT palazzolostefano dnananotechnologyforcancertherapy AT baydasamer dnananotechnologyforcancertherapy AT coronagiuseppe dnananotechnologyforcancertherapy AT toffoligiuseppe dnananotechnologyforcancertherapy AT rizzolioflavio dnananotechnologyforcancertherapy |